Ipca Laboratories UK Limited
Registered name: IPCA LABORATORIES UK LIMITED
Part of Kentish Holdings Ltd groupIpca Laboratories UK Limited made £22.6m revenue and a £1.3m loss in the year to 31 Mar 2025. read from filing text
Ipca Laboratories UK Limited’s revenue grew 91% to £22.6m in the year to 31 Mar 2025, with a loss of £1.3m and 127 employees. The company is classified under “manufacture of pharmaceutical preparations” and is based in Sunderland; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- Sunderland, North East
- Age
- 22 yrs · since 2003
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Mar 2023 | 31 Mar 2024 | 31 Mar 2025 |
|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&Lread from filing text |
| Profit & loss | |||
| Revenue (turnover) | £7m | £11.8m | £22.6m |
| Cost of sales | £6.9m | £10.6m | £17.6m |
| Gross profit | £145k | £1.2m | £5m |
| Operating profit | −£591k | £448k | −£1.4m |
| Profit before tax | −£91k | £1.4m | −£1.3m |
| Profit after tax | −£91k | £1.4m | −£1.3m |
| Profit (best available) | −£91k | £1.4m | −£1.3m |
| Staff costs | £336k | £378k | — |
| Employees (average) | 6 | 6 | 127 |
| Ratios | |||
| Profit margin | −1.3% | 12.3% | −5.8% |
| Gross margin | 2.1% | 10.2% | 22.1% |
| Revenue per employee | £1.2m | £2m | £178k |
| Profit per employee | −£15.2k | £241k | −£10.4k |
| Cash conversion | — | 17.3% | — |
| Growth (year on year) | |||
| Revenue growth | — | ▲68.3% | ▲91.1% |
| Profit growth | — | — | ▼191% |
| Headcount growth | — | 0% | ▲2017% |
| Balance sheet — indirect signals, not revenue | |||
| Cash at bank | £148k | £1m | £345k |
| Net assets | £7m | £8.5m | £8.4m |
| Fixed assets | £4.9m | £4.9m | £4.9m |
| Current assets | £5.5m | £9.4m | £9.9m |
| Debtors | £2.4m | £3.3m | £2.6m |
| Cash from operations | £1.4m | £77.6k | — |
| Source | FullAccounts · bulk data May 2024 | FullAccounts · bulk data May 2024 | FullAccounts · bulk data Jan 2026 |
How the business works
- Profit margin
- −5.8%
- Profit ÷ revenue.
- Gross margin
- 22.1%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £178k
- Revenue ÷ average employees.
- Profit per employee
- −£10.4k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 21.8%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 11.4%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▼1%
- Now £8.4m
- Cash at bank
- ▼67%
- Now £345k
- Headcount
- ▲2017%
- Now 127
- Deferred income
- —
- Now —
- Fixed assets
- ▲0%
- Now £4.9m
Group structure
Ownership chain
- Kentish Holdings Ltdultimate parent50–75%
- Kentish Sub Ltd75–100%
- Canalside N1 Ltd50–75%
- Ipca Ltd75–100%
- Ipca Laboratories UK Limitedthis company
Bands show the share of ownership each company holds in the one below it.
Subsidiaries (1)
- Onyx Scientific LimitedRev. £10.9m · Profit −£237k
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Morningside Healthcare LimitedNorthampton · Manufacture of pharmaceutical preparations
- Revenue
- £21.3m
- Profit
- £10.5m
- Staff
- 10
- Masters Pharmaceuticals LimitedElstree · Manufacture of pharmaceutical preparations
- Revenue
- £30.7m
- Profit
- £1.2m
- Staff
- 74
- Brown & Burk UK LimitedHounslow · Manufacture of pharmaceutical preparations
- Revenue
- £36m
- Profit
- £2.6m
- Staff
- 20
- Vertical Pharma Resources LimitedWest Molesey · Manufacture of pharmaceutical preparations
- Revenue
- £39.2m
- Profit
- £5.3m
- Staff
- 89
- Northumbria Pharma LtdSedgefield · Manufacture of pharmaceutical preparations
- Revenue
- £44.5m
- Profit
- £10.6k
- Staff
- 29
- Dermal Laboratories LimitedLoughton · Manufacture of pharmaceutical preparations
- Revenue
- £45.7m
- Profit
- £2.4m
- Staff
- 171
Sources
Latest figures from FullAccounts for the year to 31 Mar 2025 (profit −£1.3m), from the Companies House accounts bulk data published Jan 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.